Cinclus Pharma at Redeye Investor Forum 2024
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum in Gothenburg on April 18, 2024. You can watch the full presentation in Swedish here.
